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T lymphocytes undergo clonal expansion in response to antigenic stimulation
ofan autocrine-paracrine system basedon IL-2, the lymphocytotrophic hormone
responsible for signaling T cell cycle progression (1). One of the unique aspects
ofthis autocrine T cell growth system stems from its inducibility, in that T cells
are quiescent and remain unresponsive until stimulated via the T cell antigen
receptor complex (2, 3). Thus, asa consequenceofthe Tcell receptor-mediated
transcriptional activation ofboth the IL-2 gene and IL-2 receptor genes, T cells
become competent to receive cell cycle progression signals that are generated by
subsequent IL-2-11 interactions (2-4). Because the system is autocrine, it is likely
that regulatory controls operate topreventcontinuous cell growth. Indeed, upon
the introduction ofantigen, the production of IL-2 and the expression of IL-2-
R are both transient events that lead inevitably to a self-limiting proliferative
response (2, 5).
One approach to understanding the mechanisms by which IL-2-R function is
to determine the structure of the receptor molecule(s). In this regard, it has
recently been demonstrated that two distinct polypeptide chains express IL-2
binding sites (6-8). In conformity with the convention for nomenclature estab-
lished forother cell surfacereceptors, the larger IL-2 bindingprotein (Mr 75,000)
is designated as the a chain, whereas the smaller protein (Mr 55,000) is termed
the ,B chain (9). The # chain was the first IL-2-binding protein to become
recognized and characterized, owing primarily to its reactivity with mAb (10). It
is now appreciated that isolated ,B chains bind IL-2 with a characteristic low
affinity (Kd ^-10-8 M) (8). Individual a chains also bind IL-2 with a low affinity,
but one that is clearly distinguishable from the a chain-IL-2 interaction (Kd ^-5
x 10-1°-10-9 M) (8). By comparison, authentic, high-affinity IL-2-R binding (Kd
^x10-1 ' M) occurs only when both a chains and ,8 chains are expressed simulta-
neously (8).
The manner in which a chains and ,B chains interact to form high-affinity IL-
2-R, and the functional attributes of the individual chains compared with the
proposed a/,B heterodimeric IL-2-R are issues that have remained largely unex-
plored. Accordingly, to approach these questions directly, radiolabeled IL-2 was
used as an affinity label and also for equilibrium and kinetic binding to cells that
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express each chain individually, versus cells expressing both a and 0 chains
together. Our results, detailed in this report, indicate that both IL-2-binding
proteins contribute their unique kinetic binding characteristics to form the true
high-affinity IL-2-R, but that p75 a chains alone are responsible for stimulating
T cell proliferation.
Materials and Methods
Cell Cultures.
￿
Human leukemic cell lines YT (11), HUT-102 (12), MT-1 (13), and
ATL-2 (14) were cultured in RPMI 1640 medium (Gibco Laboratories, Grand Island,
NY) supplemented with 10% heat-inactivated FCS (56°C, 30 min) (Sterile Systems, Inc.,
Logan, UT), 50 U/ml penicillin, 50,ug/ml gentamicin, and 300 kg/ml L-glutamine in a
humidified atmosphere of 5% C02 in air. ATL-2 conditioned medium was prepared by
culturing ATL-2 cells at 3 x 105 cells/ml for 48 h (14). After removing the cells by
centrifugation (1,000 g, 10 min), the supernatants were filtered (0.2'm) and stored at
4°C before use. Individual lots of conditioned medium were standardized by titration
with YT cells, and were adjusted so that 20% conditioned medium yielded maximum
enhancement of Tac antigen expression within 24 h.
Activated human T cells were prepared by stimulating peripheral blood mononuclear
cellswith anti-T3 (1 :10,000 dilution; Ortho Pharmaceutical Co., Raritan, NJ) for 3 d. For
some experiments these cells were then cultured for an additional 10 d with 125 pM IL-
2 . To ensure maximal expression of both high-affinity and low-affinity IL-2 binding sites
by these 13-d synchronized (Go/G,) cell populations, phorbol-12,13-dibutyrate (PDBu)'
(50 ng/ml) (Consolidated Midland Co., Brewster, NY) was provided during the first 6 h
followed b~ incubation with IL-2 (125 pM) for 18 h as described previously (8). Incorpo-
ration of [ H]thymidine (2.0 ACi/ml) (Becton Dickinson and Co.) was monitored by liquid
scintillation counting (2).
Affinity Labeling ofIL-2-binding Proteins.
￿
Radioiodinated IL-2 was crosslinked to IL-2-
binding proteins according to the following protocol: Cells (5-20 x 106 cells/ml) were
incubated with 12'I-IL-2 for 1 h at 4°C, then treated with 0.3 mM disuccinimidyl suberate
(DSS) in HBSS for 15 min at 4°C, which was followed by the addition of a 50-fold molar
excess of Tris HCl, pH 7.4, to quench the reaction (8). The cells were washed and
solubilized using 0.5% NP-40, 10 mM NaCl, 1 MM M9C12, 1 mM PMSF in 10 mM Tris
HCl, pH 7.4. The nuclear-free lysates were analyzed by SDS-PAGE using reducing
conditions.
Equilibrium IL-2 Binding. Homogeneous recombinant IL-2 (15) was provided by
Takeda Chemical Industries, Ltd., Osaka, Japan as a 1 .0 mg/ml solution in ammonium
acetate buffer, pH 5 .0 . IL-2 was radioiodinated using lactoperoxidase glucose oxidase
(Enzymobeads; Bio-Rad Laboratories, Richmond, CA) according to the manufacturer's
instructions. Radioiodinated IL-2 was prepared with two different specific activities (106
cpm/pmol and 105 cpm/pmol) so that binding assays could be carried out at IL-2
concentrations ranging from 1 pM to 100 nM. Binding of IL-2 to whole cells was
performed as described previously (16), except that the radiolabeled ligands were incu-
bated together with the cell suspension (106 cells in 0.2 ml RPMI 1640 medium supple-
mented with 10% FCS), overlayed onto a 0.2 ml mixture of 80% silicone oil (Dexter
Hysol 550 fluid; Dexter Corp., Orlean, NY) and 20% paraffin oil (0-119; Fischer Scientific
Co., Fair Lawn, NJ). After a 20-min incubation at 37°C, the tubes were centrifuged
(8,500 g, 90 s), the tips of the tubes containing the cell pellet were severed, and the cell-
bound and free radioactivity were determined by solid scintillation counting. The calcu-
lated values for the number of binding sites per cell were derived by Scatchard analysis
of equilibrium binding data after subtraction of nonspecific binding determined in the
presence of 150-fold molar excess of unlabeled IL-2. The lower limit of detection for IL-
2-R was 50 binding sites/cell . The Scatchard plots shown are based on data analyzed by
the "Ligand" computer program (17).
Kinetic IL-2 Binding.
￿
Isolated membranes from the induced YT cellsand YT-2C2 cells
were used to analyze '25I-IL-2 binding to high-affinity IL-2-R and to isolated a chains,
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respectively, since a chains mediate a rapid internalization of bound IL-2 (t~j = 15 min,
our unpublishedobservations) (18); ,B chain-IL-2 binding was analyzed using whole cells,
as the rate of IL-2 internalization after binding to # chains is negligible (18). Cell
membranes were prepared by the method of Jett et al. (19) using lysis by Dounce
homogenization in 10 mM Tris HCl, pH 7.4, containing 1 MM MgCl2 and 1 mM PMSF.
After removing nuclei by centrifugation, the membrane fraction was enriched by centrif-
ugation on a 38% sucrose cushion (100,000g, 2 h), then by pelleting (100,000g, 30 min).
For dissociation, membrane or whole cells were preequilibratedwith '21I-IL-2 for 20 min
at 37°C. Dissociation was initiated by the addition of 1 uM unlabeled IL-2, and the
remaining bound 12'I-IL-2 was determined at various intervalsafterward. The concentra-
tions of ' 'I-IL-2 used varied from 5 X 10-" M(a/# dimers), 10-9 M (a chains) to 10-8
M (# chains). Association was performed by exposing membranes or whole cells to the
same concentrations of '25I-IL-2, dependent upon receptor type. At intervals, bound
versus free '25I-IL-2 were determined by centrifugation of the cells through oil, whereas
membranes were centrifuged through a 19% sucrose cushion (30,000 g, 15 min at 4°C).
The association rate constants(k)and dissociation rate constants(k')were calculated from
natural log plots of the data. The slope of the dissociation plot is -k' and that of the
association plot is k' + k(H). The half-time for dissociation is 0.693(1/k').
Results
Induction of Low- and High-affinity IL-2-binding Sites.
￿
Seeking to elucidate
further the structure-function relationshipofthea/#heterodimer modelofhigh-
affinity IL-2-R (8), we exploited two different experimental systems where it is
possible to induce p55 ,B chain expression, resulting in either the selective
augmentation oftheexpression oflow-affinity binding sites or solely high-affinity
IL-2-R. One system capitalized on the finding that IL-2 stimulation ofnormal T
cells markedly stimulates the expression oflow-affinity binding sites (5). Periph-
eral T cells were synchronized into Go/G1 by a transient proliferative expansion,
then induced to reexpress IL-2-R by a briefexposure to phorbol dibutyrate (4).
Control cells cultured without IL-2 displayed 3,370 high-affinity receptors per
cell and 9,100 low-affinity binding sites per cell (Fig. 1 A). By comparison, cells
cultured with IL-2 for 18 h are distinctly different: there are 30% fewer high-
affinity receptors expressed, while an increase in the number of low-affinity
binding sites is found (23,000 sites/cell, Fig. 1B). Therefore, as a consequence
of IL-2 exposure, the ratio of high-affinity receptors to low-affinity binding sites
changed from 1:3 to 1:9.
The membrane proteins responsible for IL-2 binding in each of these cell
populations were examined by polyacrylamide gel electrophoresis after the
formation ofcovalent bonds with bound 1251-IL-2 (8). The data obtained by this
approach further support the interpretation that high-affinity receptors are
formed by a combination ofa chains and # chains (6-8), and also show that IL-
2 binding to high-affinity receptors augments p55 ,B chain expression preferen-
tially (Fig. 1 C). Thus, for both cell populations (i.e., with or without IL-2), as the
125I-IL-2 concentration used for binding before crosslinking decreased from 5 X
10-8 M (Fig. I, lane 1) to 5 X 10-'0 M (lane 2) and to 5 X I0-11 M (lane 3), the
75,000 M,. a chain crosslinked with IL-2 (Mr 15,000) to form a 90,000 Mr
complex became progressively more discernible. Moreover, for the cell popula-
tion exposed to IL-2, the density ofthe 55,000 M,. # chain crosslinked with IL-2
to form a 70,000 Mr complex was more apparent compared with the uninduced
cells, particularly at the highest IL-2 concentration tested (Fig. 1, compare lane1058
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FIGURE 1 .
￿
IL-2 induction of low-affinity IL-2-binding sites on peripheral T cells . PDBu-
restimulated normal T cells were cultured in fresh medium with or without IL-2 for 18 h .
Scatchardanalyses display the data from '2'I-IL-2 binding to control cells (A)andIL-2-induced
cells (B) . (C) Crosslinking of 121I-IL-2 to the bindin ~roteins (M. X 10') . Control cells (left)
and IL-2-induced cells (right) were incubated with
￿
I-IL-2 at concentrations of 5 X 10-9 M
(lane 1), 5 X 10-'° M (lane 2),and 5 X 10-"M (lane 3) . After the equilibrium binding, bound
IL-2 was crosslinked to the cells using disuccinimydal suberate, andthe crosslinked complexes
were analyzed by SDS-PAGE with reducing conditions .
1 from the two populations) . Therefore, high-affinity IL-2 binding is associated
with the formationoftwo 1251-IL-2 crosslinked complexes, and the IL-2 induction
of low-affinity IL-2-binding sites correlates with an increase in the density ofp55
a chains crosslinked .
For comparison with the results obtained using normal T cells, we examined
another p55 ,8 chain-inducible system, but one that results in the stimulation of
high-affinity receptor expression rather than an excess of low-affinity binding
sites . Moreover, to facilitate the interpretation of these binding experiments we
used anti-Tac, which reacts with an epitope expressed exclusively on the p55 a
chain . A cell line (designated YT) derived from a child with acute lymphoblastic
leukemia that expresses predominantly p75 a chains can be induced to express
p55 a chains by exposure to conditioned medium derived from adultT leukemia
(ATL) cell lines (8, 11, 14). An example of such an experiment is shown in Fig.
2 . As shown in Fig . 2A, 125I-IL-2 binding to control uninducedYT cells revealsWANG AND SMITH
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FIGURE 2 .
￿
The induction of high-affinity
IL-2-R expression byYT cellsandthe effect
of anti-Tac, Scatchard plots of 1251-IL-2
binding data on YT cells cultured in control
medium (A and B) and in 20% ATL-condi-
tioned medium (induced, C and D) for 24
h . The assays were performed in the ab-
sence (O) and presence (0) of 5 X 10-8 M
anti-Tac . The top panel shows the SDS-
PAGE analysis of '251-IL-2 crosslinking ex-
periments using 10-8M 1251-IL-2, with anii-
Tac (5 X 10-8 M) absent or present during
the binding reaction before crosslinkage .
Lanes 1 and 2, uninduced YT cells; lanes 3
and 4, induced YT cells . Only the portion
of the autoradiogram containing 90,000
and 70,000 M, complexes is shown .
a very small number ofhigh-affinity receptors (Kd= 1 .6 X 10-11 M; 170 sites/cell),
and a much larger number of sites (24,000 sites/cell) that bind IL-2 with an
intermediate affinity characteristic for p75 a chains (Kd = 1 .4 X 10-9 M) . When
anti-Tac is present during the IL-2-binding reaction, high-affinity IL-2-binding
sites are no longer detectable, whereas binding to the p75 a chains remains
essentially unchanged (Fig . 2B). By comparison, the results of
121ML-2 binding
to YT cells induced to express p55 ,Q chains are much more distinct and
impressive, as shown in Fig . 2, C and D . After induction (Fig. 2C), there is a
marked increase in high-affinity IL-2-R expressed (Kd = 2.9 X 10-I ' M ; 8,400
sites/cell), and a commensurate decrease in the number of intermediate-affinity
binding sites (Kd= 10-9 M ; 9,800 sites/cell). These data are consistent with some
of the p75 a chains combining with p55 ,B chains to form high-affinity IL-2-R,
an interpretation that is substantiated further by the data obtained from 1251-IL-
2 binding to this cell population when the assays are performed in the presence
ofanti-Tac (Fig . 2D) . Anti-Tac abolishes all detectable high-affinity IL-2 binding,
and returns the number of p75 a chain binding sites to the high-density (23,000
sites/cell) observed before the induction of p55 a chain expression (Fig. 2,
compareD with B) .
The kind of IL-2-binding proteins detectable on these cells by 1251-IL-2
crosslinkage experiments performed in the presence and absence of anti-Tac is
shown at the top of Fig. 2 . As anticipated, only a single 90,000 M, I25I-IL-2-
crosslinked complex was observed using uninduced controlYT cells (Fig . 2, lane
1), and anti-Tac had no effect on the intensity of the band observed on the
autoradiograph (Fig . 2, lane 2) . By comparison, YT cells induced to express
high-affinity receptors display two distinct 125I-IL-2-crosslinked complexes M,
90,000 and 70,000 (Fig . 2, lane 3), and the presence of anti-Tac prevented the106)0
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FIGURE 3.
￿
Kinetics of IL-2 binding at 37°C. Natural
log plotsof data are shown for dissociation (A) and asso-
ciation(B)of '211-IL-2 at 37°C to isolated membranesfor
the analysis of high-affinity a/0dimers (induced YT cells,
A) and isolated a chains (YT-2C2 cells, /), whereas iso-
lated 6 chains were examined using whole cells (MT-1
u
￿
cells, 4p). For dissociation, the specific binding at t = 0,
10
￿
20
￿
30
￿
(HR)o, was measured in quadruplicate, while at intervals
during dissociation, duplicate determinations were made
to determine HR. For association, at the intervals indi-
cated, duplicate aliquots were determined for: HR =
bound "5I-IL-2 at time t and(HR). = bound '2'1-IL-2 at
equilibrium. All thedata shown arecorrectedfornonspe-
cificbinding. Theduplicatevalues obtained forall points
varied <10-15% from the mean.
formation of the 70,000 M, complex, but not the formation of the 90,000 Mr
complex (Fig. 2, lane 4). Accordingly, from these data it is apparent that IL-2-R
p75 a chains and p55 ,B chains cooperate to form high-affinity receptors, and
that this cooperative interaction can be readily disrupted, as shown so distinctly
by the effect ofanti-Tac on both the binding and crosslinking experiments.
Kinetic Binding Studies Reveal a Unique Form of Cooperative Ligand Bind-
ing. Experiments that provide information as to the rates of Lgand-receptor
interactions often can lead to insights on reaction mechanisms unobtainable by
equilibrium measurements. Therefore, to investigate further the nature of the
a/# heterodimer, we next examined in detail the kinetics of 12'1-IL-2 binding to
the three distinct kinds of binding sites (i.e., a chains, # chains, and a/,B
heterodimers). To perform kinetic binding experiments unambiguously, we
exploited leukemic cell linesexpressing solely either p75 a chains (YT-2C2 cells)
(8), or p55 ,B chains (MT-1 cells) (13) to compare with cells displaying the a/#
high-affinity receptor complex (induced YT cells and HUT-102 cells) (12).
Moreover, to provide an independent assessment of the equilibrium binding
constants, which were determined at 37°C, all kinetic binding determinations
were also performed at this temperature, thereby generating data ofphysiologic
relevance with respect to the reaction rates.
Natural log plots of data representative of three separate kinetic binding
experiments are displayed in Fig. 3, and the kinetic binding constants calculated
on the basis of these data are listed in Table I. From these results it is evident
that the kinetics of IL-2 binding to isolated p75 a chains are markedly different
compared with those obtained using isolated p55 ,8 chains, even though the
equilibrium dissociation constants obtained forbindingto thesetwo chains differChain
WANG AND SMITH
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TABLE I
Kinetic andEquilibrium IL-2 BindingConstants
Kinetic bindingconstants* Equilibrium dissociation
constants
* a Chain, YT-2C2 membranes;#chain, MT-1 cells; a, ,B chains, induced YT membranes.
$Calculated from thedata shown in Fig. 3.
Mean ±SEM from eight separate equilibrium binding experiments.
only 10-fold: IL-2 binds to and dissociates from p55 ,B chains much more rapidly
than to p75 a chains. The magnitude of the differences are readily appreciated
by examination of the plot ofdissociation rate data (Fig. 3A), where it is obvious
that theslopeofthe data for IL-2 p55 ,B chain dissociation is very steep compared
with the data for IL-2 p75 a chain dissociation. Because ligand dissociation
follows first-order kinetics, the half-times (tf,) for dissociation can be used to
obtain meaningful comparisons. Therefore, the ty, for IL-2 dissociation from
p55 ,8 chains calculated from the dissociation rate constantdiffers by three orders
of magnitude compared to the value obtained with p75 a chains (1 .7 s versus
2,770 s [46 min] respectively) (Table I).
Because IL-2 dissociates from p55 ,B chains much more rapidly than from a
chains, we expected the rates of IL-2 association to the two chains to reflect the
dissociation rates. When determined directly, IL-2 was found to associate with
the p55,6 chain bindingsite very rapidly, at a rate that was especially noteworthy
when compared with the much slower association of IL-2 to p75 a chains (Fig.
3B). The association rate constants (k) calculated from these data revealed that
the rate constant for IL-2-p55# chain association is 100 times greater than the
rate constant for IL-2-p75a chain association, and approaches the values for
association rate constants that are determined by diffusion alone (k = 1 .4 X
107/M-s; Table 1). Accordingly, for the first time it could beseen that IL-2 binds
to and dissociates from p55 ,8 chains very rapidly, while the kinetics of IL-2
binding to p75 a chains are much slower, thereby contributing further data
indicating that p75 a chains and p55 (3 chains have separate and distinct
attributes.
Even more distinctive and provocative were the results obtained from kinetic
binding determinations analyzing a/,B heterodimers. From the data shown in
Fig. 3, it is readily appreciated that IL-2 binding to the a/,B chain complex is a
synthesis of the rates of binding to each isolated chain. Thus, IL-2 binding to
high-affinity receptors takes on the characteristics of the p55 ,8 chain for the
forward reaction, so that it associates rapidly to the a/,B dimer. It should be
emphasized that the slope oftheexperimentally determined association rate(Fig.
3B) is a function of the sum of the dissociation rate constant and the product of
the association rate constant and hormone concentration (k' + k[H]). Therefore,
Dissociation
s-'
(k')
to
Association
(k)
M-' . s-'
Kinetic (k'/k) Equilibrium:
M
a 2.5 X 10-4 46 min 3.8 X 105 0.7 X 10-9 1.2 (t 0.1) X 10-9
0 4.0 X 10-' 1.7s 1.4 x 107 2.9 X 10-s 1.4 (t 0.1) X 10-8
a,,B 2.3 X 10-4 50 min 3.1 X 107 0.7 X 10-" 1.3 (t 0.1) X 10-"1062
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even though the natural log plot of the association data shown in Fig. 3B has a
slope for IL-2 association with a/# dimers that is intermediate compared with
those of individual p75 a chains and individual p55 # chains, the association rate
constant calculated from these data is equivalent to the p55 a chain-IL-2
association rate constant (k = 3 .1 X 107/M - s; Table I). In contrast, the reverse
reaction assumes the behavior of IL-2 as if it were bound solely to p75 a chains
(Fig. 3A). Actually, the dissociation rate constant calculated from these data is
essentially identical to the dissociation rate constant calculated for isolated p75
a chains (i.e., k' = 2.5 X 10_'/s for p75 a chains and k' = 2.3 X 10-'/s for alo
dimers). As expected, since the equilibrium dissociation constant is an expression
of the ratio of the dissociation rate constant and association rate constant (i.e.,
Kd = k'/k), the biologic consequence of combining a slow dissociation rate (k' =
2.3 X 10-'/s) with a very fast association rate (k = 3 .1 X 107/M .s) is a very high
affinity, with a calculated equilibrium dissociation constant (Kd = 0.74 X 10-11
M) that differs 100-fold from that calculated for IL-2 binding to the p75 a chain
(Kd = 0 .7 X 10-9 M), and 1,000-fold from the Kd calculated for IL-2 binding to
individual p55 Q chains (2.9 X 10-5 M).
It is noteworthy that the validity and accuracy of the association and dissocia-
tion rate constants calculated from the natural log plots of the experimental data
(Fig. 3) for each type of IL-2-binding site (i.e., a and ,B, and af) are confirmed
by the values of the equilibrium constants obtained by calculating the ratio of
the rate constants. Because the values calculated from the rate constants are
comparable with the experimentally derived equilibrium dissociation constants
(Table I), it is unlikely that any one of the individual rate constants calculated
from the kinetic data obtained experimentally is erroneous. Consequently, the
construction of this kinetic hybrid ligand receptor interaction using two distinct
IL-2-binding proteins makes for a biologically relevant hormone receptor of
exceptional functional efficiency: Because the 50% effective concentration (EC5o)
is determined by the Kd (^" 10-'1 M), very low IL-2 concentrations (i.e., <10-1°
M) will trigger a T cell proliferative response.
a Chains Are Responsible for Stimulating Cell Cycle Progression.
￿
Even though
the kinetic and equilibrium binding studies revealed how a and ,8 chains cooperate
to form a very-high-affinity IL-2-R, these data alone did not indicate which chain
is actually responsible for transducing a growth signal to the cell. However, in
this regard, transfection experiments where non-T cells were made to express
p55 # chains in the absence of p75 a chains showed that p55,6 chains alone are
incapable of stimulating cell proliferation (20, 21). Therefore, it remained to be
determined whether the p75 a chain itself could function in this regard, or
whether the complete a/,B heterodimer is essential. To approach this question
directly, we capitalized on our findings with YT cells showing that anti-Tac
prevents IL-2 binding to p55 ,B chains and disrupts high-affinity a/o dimer
binding, leaving isolated p75 a chain IL-2 binding intact. A similar approach was
tested using normal T cells that were first activated by a 3-d culture with anti-
T3 to render the cell population IL-2 responsive (4). As shown in Fig. 4A, these
T cell blasts express both high-affinity receptors (Kd = 2 .7 X 10- ' 1 M; 1,900
sites/cell) as well as an excess of low-affinity IL-2-binding sites (Kd = 1 .4 X 10-5
M; 11,500 sites/cell). However, when binding is performed with anti-Tac present60
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FIGURE 4.
￿
Theeffect o£ anti-Tac on "I-IL-2 binding andthe IL-2-dependent proliferative
response of anti-T3-activated normal T cells. Peripheral mononuclear cells were activated
with anti-T3 for 3d, then washed before 1251-IL-2 bindingassays. Aand Bare Scatchard plots
of binding data in the presence of control normal mouse IgG (5 X 10-8 M) (A), and in the
presence ofanti-Tac (5 X 10-8 M) (B). (C) ['H]TdRincorporation by aliquots of the anti-T3-
activated cells. The cells were cultured (105 cells/ml) in RPMI 1640 medium 10% FCS, with
5.0 X 10-8 M normal mouse IgG (0), and with 5.0 X 10-8 M anti-Tac (0) in the presence of
rIL-2 from 10-'s-10-1 M. Thedata shown are from day 3 of culture and are representative
of data also obtained on days 1 and 2. The standard error of the mean values shown were
<5%, determined on quadruplicate samples.
in 5-10-fold excess of the concentration necessary to saturate all Tac epitopes
(5 X 10-e M), neither high-affinity receptors nor low-affinity IL-2-binding sites
are occupied. Instead, the only detectable I25I-IL-2-binding occurs to sites that
express an intermediate affinity (Kd = 3.6 X 10`0 M), even though the assay was
performed with very high I25I-IL-2 concentrations (510-7 M) (Fig. 4B). More-
over, the number of sites occupied (2,100 sites/cell), is indistinguishable experi-
mentally from the number ofhigh-affinity IL-2-R detectable in the absence of
anti-Tac (1,900 sites/cell). Therefore, in a fashion similar to its effect on YT
cells, on normal T cell blasts anti-Tac functions to completely prevent IL-2
binding to p55 0 chains and a/,B dimers, and in doing so it reveals the IL-2
binding characteristic for isolated p75 a chains.
Having created normal Tcells capable ofbinding IL-2 solely via p75 a chains,
it was possible to test the hypothesis as to whether an IL-2-p75a chain interaction
can promote growth, or alternatively, whether binding to high-affinity a/,B
heterodimers is required. To this end, aliquots of the anti-T3-activated T cells
were washed free ofany IL-2 produced in situ, then cultured with anti-Tac (5 X
10-8 M) in the presence ofa broad range of IL-2 concentrations (10-12-10-7 M).
Parenthetically, it should be emphasized that even the highest concentration of
IL-2 used (10-7 M)was insufficient to compete with anti-Tac for binding to high-
affinity receptors and isolated p55 a chains, as shown by the binding assay (Fig.1064
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4B). Therefore, if IL-2 binding to high-affinity receptors is necessary for growth
signal transduction, T cell blasts cultured with anti-Tac should remain unrespon-
sive to IL-2. Alternatively, if individual p75 a chains can function to stimulate T
cell growth, we expected that the presence of anti-Tac would function simply to
shift the IL-2 dose-response curve, so that the effective IL-2 concentrations
would be predictable from those necessary to saturate the p75 a chains. The
results, depicted in Fig. 4C, show that the IL-2-p75a chain interaction alone is
sufficient to signal the complete T cell growth response: The presence of anti-
Tac does not inhibit IL-2 stimulation of proliferation, despite completely pre-
venting IL-2 binding to both isolated p55 ,Q chains and high-affinity a/,8 dimers.
Instead, the IL-2 concentrations required to trigger the response are simply
increased 15-fold by the presence of anti-Tac, a result anticipated by the 13-fold
higher concentrations of IL-2 necessary to bind to isolated p75 a chains versus
high-affinity a/# dimers.
Discussion
From the experimental findings accumulated in the course of these studies, it
is evident that the characteristic high-affinity receptor for IL-2 is formed by a
unique cooperative functional interaction between the two separate and distinct
binding sites expressed on p75 a and p55 ,Q chains. The most intriguing aspect
of this bimolecular receptor system relates to the synergistic manner in which
the association rate is contributed by the rapidly reacting p55 ,Q chain, whereas
the dissociation rate is determined by the slowly reacting p75 a chain. These
findings relegate the p55 a chain to function essentially as a helper binding site
with no signaling capacity of its own, particularly as we now realize that the
larger p75 a chain is capable of stimulating cell division without the assistance
of the p55 ,8 chain.
The formation of high-affinity IL-2-R by the combination of distinct binding
sites contributed by two separate chains thus far represents a unique example of
a way to form specific, high-affinity ligand-receptor reaction complexes. How-
ever, the marked efficiency of ligand binding that results from the kinetic hybrid
a/,Q dimer IL-2-R leads to the expectation that other lymphokine and growth
factor receptor systems will prove to be similar to the one detailed here for IL-
2. In this regard, it is particularly noteworthy that IL-3 crosslinkage experiments
have also revealed two binding proteins, identical in size to the IL-2-R a and ,B
chains (22). Moreover, it may be more than mere coincidence that nerve growth
factor (NGF) receptors appear to be so similar to IL-2-R . For example, two
classes of NGF receptors are expressed (i.e., Kd = 10" and 10-9 M), but no
structural explanation for the 100-fold difference in binding affinities has yet
been disclosed (23). Recently, genomic and cDNA clones encoding a single NGF
receptor chain have been isolated: Transfectants expressing this chain bind NGF
with only the characteristic "fast-reacting" low affinity (24-26). Based on our
findings regarding the dynamic cooperative interaction between IL-2-R p75 a
and p55 a chains in the formation of high-affinity receptors, it is entirely
conceivable that high-affinity NGF receptors are likewise made up of two ligand-
binding chains. Indeed, recent crosslinkage studies suggest that there may be an
additional protein that is also capable of binding NGF (27).WANG AND SMITH
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It is worthy of emphasis that there is no indication that the interaction between
the a and S chains involves a covalent disulfide linkage. Instead, all of the data
point to a noncovalent association as being responsible for the formation of the
high-affinity binding site. Thus, anti-Tac has the effect of actually exposing IL-
2 binding to individual p75 a chains, which on normal T cells can only be
derived from a/,B dimers. Therefore, as displayed so convincingly by the com-
bined results of the 125I-IL-2 binding and crosslinking experiments performed in
the presence of anti-Tac, the net effect of the disruption of high-affinity binding
is intermediate-affinity binding to the 75,000 M,. a chain. Moreover, the reali-
zation that the a chain-# chain interaction occurs via noncovalent forces that
are easily disruptable by anti-Tac indicates that the interaction between these
two chains is itself likely to be dynamic, and thus subject to association and
dissociation. It follows that the marked induction of ,B chains upon IL-2 binding
to high-affinity IL-2-R would favor the formation of a/,8 heterodimers, especially
as the mass action of a higher density of p55 ,B chains would promote association
with p75 a chains. This reasoning is especially compelling, as there is no evidence
that p55 ,B chains have any biologic role beyond functioning to cooperate with
p75 a chains to make high-affinity IL-2-binding sites.
The results derived from the kinetic binding experiments with isolated a
chains, isolated ,B chains, and a/,B heterodimers also provide exceptional mecha-
nistic information pertaining to the structure-activity relationships of the respec-
tive IL-2-binding proteins. IL-2 binding to isolated p55 ,B chains, which are
generally expressed in 10-20-foldexcess ofa/,B heterodimers on actively growing
T cells, can now be envisioned to convert the actual interaction between IL-2
and a/,B heterodimers from a three-dimensional search to a two-dimensional
search in the plane of the membrane, a concept proposed originally by Adam
and Delbruck (28). A similar, low-affinity, high-capacity reaction can be demon-
strated to be operative in the interaction between endonucleases and nonspecific
sites on DNA, as compared with the high-affinity specific cleavage sites deter-
mined by the DNA sequence (29, 30). A low-affinity, rapidly reversible reaction
occurs between the endonuclease and nonspecific DNA sequences. The search
for the specific sites, where the enzyme binds with high affinity, is thus made
linear and is reduced from an infinitely complex three-dimensional problem to
a relatively simple two-dimensional quest. The singular aspect of the structure-
activity relationships of the IL-2-binding proteins, when interpreted in the light
of this concept, resides in the probability that the noncovalent formation of
authentic, high-affinity IL-2-R, and the induction of an excess ofrapidly reacting,
low-affinity p55 0 chains, may well delineate the principle guiding the selection
and conservation of lymphokine-receptor interaction systems.
The finding that the p75 a chain alone appears to transduce a growth signal
to the cell is entirely consistent with the previous results obtained with p55 0
chain transfectants, which proved to be nonfunctional (20, 21). Moreover, the
data obtained with normal T cells using anti-Tac are identical to those obtained
previously using the MLA-144 cell line. This cell line both produces and responds
to IL-2, as shown by our studies using glucocorticoids, which block proliferation
by inhibiting IL-2 production (31) . Subsequent to the report by Tsudo et al. (7)
showing that MLA-144 cells express solely p75 a chains, we repeated our earlier1066
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studies and confirmed that MLA-144 cells express a single class ofintermediate-
affinity receptors that arecapable oftransducinga growth signal (32). Itis worthy
ofemphasis that the effect of anti-Tac on normal T cells, in causing a shift to
higher IL-2 concentrations for a growth response, is entirely consistent with our
originally reported data (10). Thus, at low IL-2 concentrations (e.g., 10" M),
anti-Tac completely abrogates T cell growth (Fig. 4C). However, as the IL-2
concentration isincreased, the inhibitory effect ofanti-Tac becomesprogressively
lessevident. Thecompetitive effect ofanti-Tac on IL-2-binding and proliferation
ofT cells was previously attributed to a simple mass action equilibrium between
IL-2 and anti-Tac both vying for a single high-affinity receptor molecule (33).
However, in these earlier experiments, the effect of anti-Tac to decrease the
number as well as the affinity of IL-2-binding sites went unnoticed. From the
'251-IL-2 binding and crosslinking results reported here, it is evident that by
binding to ,Bchains, anti-Tac prevents IL-2 binding to the a/,#dimer. Therefore,
anti-Tac disrupts the cooperation between p75 a chains and p55 ,8 chains, so
that there can be no simple competitive relationship between anti-Tac, IL-2, and
a/,B dimers. Instead, the presence of saturating concentrations of anti-Tac
guarantees that only p75 a chains are available for IL-2 binding.
Confirmation ofthe results regarding the signaling capacity ofthe p75 a chain
must now be sought using alternative approaches, such as transfection methods
and reconstitution experiments using purified p75 a chains. Meanwhile, the
realization that IL-2-R p75 a chains convey a biologic response in the absence
of IL-2 binding to p55 0 chains provides an acceptable explanation for several
ofthe heretofore perplexing findings where IL-2 stimulates a biologic response,
yet IL-2-R are undetectable usingantibodies reactive solely with the p55 ,0chain.
For example, immature human thymocytes proliferate in response to IL-2,
provided contact with thymic stromal cells is maintained in vitro (B. F. Haynes,
personal communication). Of considerable importance regarding the present
findings, these "double negative" fetal thymocytes lack detectable Tac antigen
when initially isolated, even though they are IL-2 responsive. Accordingly, it
appears that during ontogeny, IL-2-R p75 a chains are expressed before p55 0
chains, and could be responsible for the marked proliferative activity of this
thymic subset as it occurs in vivo. The IL-2 reactivity ofnatural killer cells might
also be attributable to the expression ofp75 a chains, particularly since high IL-
2 concentrations are generally required to activate this cell type (34). A similar
argument ispersuasive forexplaining arole for IL-2 in B cell responses, especially
as activated human and murine B cells express small numbers of lower-affinity
IL-2-binding sites (35, 36). Thus, we look forward to further, more definitive
studies dealing with these issues, once p75 a chain-specific reagents have been
generated.
Summary
High-affinity IL-2-R binding results from an exceptional type of cooperative
interaction between two IL-2-binding proteins termed a and ,B. When expressed
together on the cell surface, these two distinct chains form a noncovalent kinetic
hybrid receptor complex that exploits a rapid association rate contributed by the
p55 ,B chain and a slow dissociation rate characteristic for the p75 a chain. Thep75 a chains signal cell growth, whereas the p55 ,B chains only facilitate IL-2
binding by serving as helper binding sites, having no discernible signaling role
themselves. The unique functional implications of this structural organization
indicate that this cooperative bimolecular arrangement reflects a general mech-
anism by which the efficiency of surface receptors can be enhanced markedly.
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